BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12794227)

  • 1. Treatment of Candida glabrata using topical amphotericin B and flucytosine.
    Shann S; Wilson J
    Sex Transm Infect; 2003 Jun; 79(3):265-6. PubMed ID: 12794227
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.
    White DJ; Habib AR; Vanthuyne A; Langford S; Symonds M
    Sex Transm Infect; 2001 Jun; 77(3):212-3. PubMed ID: 11402233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and management of non-albicans vaginal candidiasis.
    Hettiarachchi N; Ashbee HR; Wilson JD
    Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory Candida krusei vaginitis with topical amphotericin B.
    Chamorro-de-Vega E; Gil-Navarro MV; Perez-Blanco JL
    Med Clin (Barc); 2016 Dec; 147(12):565-566. PubMed ID: 27567339
    [No Abstract]   [Full Text] [Related]  

  • 5. A case series of the management of symptomatic azole-resistant candida.
    Challenor R; Pinsent S; Ekanayaka R
    Int J STD AIDS; 2012 May; 23(5):375-6. PubMed ID: 22648899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
    Sobel JD; Chaim W; Nagappan V; Leaman D
    Am J Obstet Gynecol; 2003 Nov; 189(5):1297-300. PubMed ID: 14634557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis.
    Wong PN; Lo KY; Tong GM; Chan SF; Lo MW; Mak SK; Wong AK
    Perit Dial Int; 2008; 28(2):155-62. PubMed ID: 18332451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories.
    Phillips AJ
    Am J Obstet Gynecol; 2005 Jun; 192(6):2009-12; discussion 2012-3. PubMed ID: 15970877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory urinary tract and vulvovaginal infection caused by Candida krusei.
    Sivasubramanian G; Sobel JD
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Nov; 20(11):1379-81. PubMed ID: 19834757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal drugs in current use: a review.
    Clayton YM
    Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):15-8. PubMed ID: 122688
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Candida arthritis with flucytosine and amphotericin B.
    Weisse ME; Person DA; Berkenbaugh JT
    J Perinatol; 1993; 13(5):402-4. PubMed ID: 8263628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Sukeepaisarncharoen W; Thavornpitak Y
    J Med Assoc Thai; 1997 Jul; 80(7):416-25. PubMed ID: 9277070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Denning DW; Drusano GL
    J Infect Dis; 2005 Aug; 192(4):673-80. PubMed ID: 16028137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida lung abscess: successful treatment with amphotericin B and 5-flucytosine.
    Schiffman RL; Johnson TS; Weinberger SE; Weiss ST; Schwartz A
    Am Rev Respir Dis; 1982 Jun; 125(6):766-8. PubMed ID: 7091886
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.